Fortrea Holdings (FTRE) Tax Provisions (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Tax Provisions came in at $12.0 million in Q2 2026, up 185.71% YoY from $4.2 million in Q2 2025, and up 6.19% on a QoQ basis from $11.3 million in Q1 2026.
Analysis
Fortrea Holdings (FTRE) Tax Provisions (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has 5 years of Tax Provisions data on file, last reported at $12.0 million in Q2 2026.
- Quarterly Tax Provisions rose 185.71% year-over-year to $12.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $7.4 million (up 825.0% YoY) and the FY2025 annual result came in at $3.2 million, up 191.43% from the prior year.
- Tax Provisions climbed to $12.0 million in Q2 2026, from $11.3 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $17.2 million in Q2 2022 to a low of -$17.3 million in Q3 2024.
- A 5-year average of $3.5 million and a median of $4.2 million in 2025 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2023 — Tax Provisions sank 215.09% — and 2025, when it soared 263.41%.
- Tracing FTRE's Tax Provisions over 5 years: stood at $5.3 million in 2022, then slumped by 215.09% to -$6.1 million in 2023, then soared by 83.61% to -$1.0 million in 2024, then tumbled by 210.0% to -$3.1 million in 2025, then soared by 487.1% to $12.0 million in 2026.
- The last three Tax Provisions figures came in at $12.0 million (Q2 2026), $11.3 million (Q1 2026), and -$3.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 63.70 Bn | 58.52 Bn | 1.37 Bn | -59.00 Mn |
| 4 | Moderna | 57.56 Bn | 52.42 Bn | 52.00 Mn | 15.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 40.16 Bn | 35.06 Bn | 1.53 Bn | 75.45 Mn |
| 7 | Alnylam Pharmaceuticals | 35.63 Bn | 32.32 Bn | 992.69 Mn | 13.31 Mn |
| 8 | Royalty Pharma | 28.63 Bn | 27.79 Bn | - | - |
| 9 | Insmed | 27.73 Bn | 26.57 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Fortrea Holdings | 1.73 Bn | 1.56 Bn | 139.20 Mn | 12.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.00 Mn |
| Mar 31, 2026 | 11.30 Mn |
| Dec 31, 2025 | -3.10 Mn |
| Sep 30, 2025 | -12.80 Mn |
| Jun 30, 2025 | 4.20 Mn |
| Mar 31, 2025 | 14.90 Mn |
| Dec 31, 2024 | -1.00 Mn |
| Sep 30, 2024 | -17.30 Mn |
| Jun 30, 2024 | 10.70 Mn |
| Mar 31, 2024 | 4.10 Mn |
| Dec 31, 2023 | -6.10 Mn |
| Sep 30, 2023 | -5.80 Mn |
| Jun 30, 2023 | 11.60 Mn |
| Mar 31, 2023 | 1.50 Mn |
| Dec 31, 2022 | 5.30 Mn |
| Sep 30, 2022 | 13.60 Mn |
| Jun 30, 2022 | 17.20 Mn |